Literature DB >> 16476413

Significant association between the genetic variations in the 5' end of the N-methyl-D-aspartate receptor subunit gene GRIN1 and schizophrenia.

Xinzhi Zhao1, Huafang Li, Yongyong Shi, Ruqi Tang, Wuyan Chen, Jixia Liu, Guoyin Feng, Jianguo Shi, Lijuan Yan, Huijun Liu, Lin He.   

Abstract

BACKGROUND: N-methyl-D-aspartate (NMDA) receptors play important roles in many neurophysiological processes. Evidence from previous studies indicate that NMDA receptors contribute to the pathophysiology of schizophrenia. Two NMDA receptor subunit genes, GRIN1 and GRIN2A, are both good candidate genes for schizophrenia.
METHOD: We genotyped five single nucleotide polymorphisms (SNPs) in GRIN1 and two in GRIN2A in 2455 Han Chinese subjects, including population- and family-based samples, and performed case-control and transmission disequilibrium test (TDT) analyses. A microsatellite in GRIN2A was genotyped in population-based samples and a Mann-Whitney U test was performed.
RESULTS: A highly significant association was detected at the 5' end of GRIN1. Analyses of single variants and multiple-locus haplotypes indicate that the association is mainly generated by rs11146020 (case-control study: p = .0000013, odds ratio = .61, 95% confidence interval .50-.74; TDT: p = .0019, T/NT = 79/123). No association was found in the GRIN2A polymorphisms.
CONCLUSIONS: Our results provide support for the hypothesis that NMDA receptors are an important factor in schizophrenia. Moreover, rs11146020 is located in 5' untranslated region where several functional elements have been found. Hence, the SNP is a potential candidate in altering risk for schizophrenia and worthy of further replication and functional study.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16476413     DOI: 10.1016/j.biopsych.2005.10.023

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  16 in total

1.  Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia.

Authors:  Tiffany A Greenwood; Laura C Lazzeroni; Sarah S Murray; Kristin S Cadenhead; Monica E Calkins; Dorcas J Dobie; Michael F Green; Raquel E Gur; Ruben C Gur; Gary Hardiman; John R Kelsoe; Sherry Leonard; Gregory A Light; Keith H Nuechterlein; Ann Olincy; Allen D Radant; Nicholas J Schork; Larry J Seidman; Larry J Siever; Jeremy M Silverman; William S Stone; Neal R Swerdlow; Debby W Tsuang; Ming T Tsuang; Bruce I Turetsky; Robert Freedman; David L Braff
Journal:  Am J Psychiatry       Date:  2011-04-15       Impact factor: 18.112

Review 2.  Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders.

Authors:  R Gao; P Penzes
Journal:  Curr Mol Med       Date:  2015       Impact factor: 2.222

3.  Association between the G1001C polymorphism in the GRIN1 gene promoter and schizophrenia in the Iranian population.

Authors:  Hamid Galehdari; Atefeh Pooryasin; Alimohammad Foroughmand; Setareh Daneshmand; Mostafa Saadat
Journal:  J Mol Neurosci       Date:  2008-09-16       Impact factor: 3.444

Review 4.  Repeated ketamine administration alters N-methyl-D-aspartic acid receptor subunit gene expression: implication of genetic vulnerability for ketamine abuse and ketamine psychosis in humans.

Authors:  Ke Xu; Robert H Lipsky
Journal:  Exp Biol Med (Maywood)       Date:  2014-09-21

Review 5.  Modelling prefrontal cortex deficits in schizophrenia: implications for treatment.

Authors:  J A Pratt; C Winchester; A Egerton; S M Cochran; B J Morris
Journal:  Br J Pharmacol       Date:  2008-03       Impact factor: 8.739

Review 6.  Glutamatergic abnormalities of the thalamus in schizophrenia: a systematic review.

Authors:  L Watis; S H Chen; H C Chua; S A Chong; K Sim
Journal:  J Neural Transm (Vienna)       Date:  2008-02-26       Impact factor: 3.575

7.  GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction.

Authors:  M J Gandal; J Sisti; K Klook; P I Ortinski; V Leitman; Y Liang; T Thieu; R Anderson; R C Pierce; G Jonak; R E Gur; G Carlson; S J Siegel
Journal:  Transl Psychiatry       Date:  2012-07-17       Impact factor: 6.222

8.  Transcriptomic analysis of autistic brain reveals convergent molecular pathology.

Authors:  Irina Voineagu; Xinchen Wang; Patrick Johnston; Jennifer K Lowe; Yuan Tian; Steve Horvath; Jonathan Mill; Rita M Cantor; Benjamin J Blencowe; Daniel H Geschwind
Journal:  Nature       Date:  2011-05-25       Impact factor: 49.962

9.  ENU-mutagenesis mice with a non-synonymous mutation in Grin1 exhibit abnormal anxiety-like behaviors, impaired fear memory, and decreased acoustic startle response.

Authors:  Juzoh Umemori; Keizo Takao; Hisatsugu Koshimizu; Satoko Hattori; Tamio Furuse; Shigeharu Wakana; Tsuyoshi Miyakawa
Journal:  BMC Res Notes       Date:  2013-05-21

Review 10.  Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions.

Authors:  James Varley; Angela Vincent; Sarosh R Irani
Journal:  J Neurol       Date:  2014-12-10       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.